PETS PetMed Express Inc.

PetMed Express Appoints Matt Hulett, Former Rosetta Stone President, as CEO & President, and Member of the Board of Directors

PetMed Express Appoints Matt Hulett, Former Rosetta Stone President, as CEO & President, and Member of the Board of Directors

DELRAY BEACH, Fla., Aug. 31, 2021 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS), America's Most Trusted Pet Pharmacy, today announced the appointment of Matt Hulett as its Chief Executive Officer and President, and member of the Board of Directors.

Hulett is a seasoned technology executive with more than 30 years of experience building and leading world-class digital consumer companies. Hulett has helped lead the growth of companies in both the private and public sectors, including Rosetta Stone, Expedia, and RealNetworks, as a public company president as well as a private company CEO. As President of Rosetta Stone, Hulett was responsible for driving the transformation and growth for all aspects of the company's language business, which resulted in two liquidity events, each of which delivered substantial shareholder value.

“Matt brings deep experience in using technology to delight customers as well as a wealth of knowledge gained from leading numerous digital transformations,” said Dr. Gian Fulgoni, Board Chairman. “As the market for digital pet pharmacy and healthcare continues to grow, we look forward to seeing Matt leverage PetMeds’ many assets and seeing our business flourish under his leadership.”

Matt Hulett commented, “I am very excited about the future of PetMeds. Not only is the pet market huge at $100 billion in annual sales with 67 percent of US households owning pets, but PetMeds has established itself as a trusted leader in providing critical healthcare to much-loved pets everywhere for over 25 years. I look forward to leading the company, as it builds on its solid and profitable foundation and enters new markets to generate strong growth in the years ahead. Speaking from experience as a pet parent, pets provide important physical and mental health benefits to individuals and to society as a whole, and I am deeply committed to growing businesses that provide meaningful social impact.”

Founded in 1996, PetMed Express is America’s Most Trusted Pet Pharmacy ®, providing prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to the consumer through its website at and through its 1-800-PetMeds toll free number.



This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2021. The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.

For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 561-526-4444.



EN
31/08/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PetMed Express Inc.

 PRESS RELEASE

PetMed Express Comments on Unsolicited and Non-Binding Acquisition Pro...

PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited No Stockholder Action Required at this Time DELRAY BEACH, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company” or “PetMeds”), today confirmed that it has received an unsolicited and non-binding acquisition proposal from SilverCape Investments Limited, a Singapore-based investment firm, to acquire all of the outstanding shares of the Company for $4 per share in cash, subject to variou...

 PRESS RELEASE

PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets ...

PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them DELRAY BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today unveiled its new Holiday Collection, a curated selection of health, wellness, and lifestyle products designed for pet parents who want to give purposeful, practical gifts this season. Unlike traditional pet gifts such as toys or beds, PetMeds’ giftable assortment focuses on products that improve pets’ everyday health, comfort, safety...

 PRESS RELEASE

PetMeds Extends Existing Shareholder Rights Plan

PetMeds Extends Existing Shareholder Rights Plan DELRAY BEACH, Fla., Nov. 26, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today announced that its Board of Directors (the “Board”) has unanimously approved an amendment to the Company’s existing shareholder rights plan (the “Rights Plan”), pursuant to which the expiration date of the Rights was extended for one year from the close of business on December 2, 2025 until the close of business on December 2, 2026. All other terms and conditions of the Rights Plan ...

 PRESS RELEASE

PetMed Express, Inc. Announces Preliminary Second Quarter Results and ...

PetMed Express, Inc. Announces Preliminary Second Quarter Results and Filing of Form 12b-25; Company Receives Expected Notice of Non-Compliance from Nasdaq DELRAY BEACH, Fla., Nov. 13, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today announced preliminary second quarter fiscal year 2026 results and filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission. The Company is unable to file its Form 10-Q for the quarter ended September 30, 2025 within the prescribed time period...

 PRESS RELEASE

PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as ...

PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee Chair Seasoned corporate director brings extensive expertise in audit, accounting, and internal controls Fourth independent director to join the board since 2024 DELRAY BEACH, Fla., Oct. 20, 2025 (GLOBE NEWSWIRE) -- , d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today announced the appointment, effective immediately, of James LaCamp to the Company’s Board of Directors (the “Board”), and effective October 30, Mr. LaCamp will become Chair of the Audit Commit...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch